Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.
Ali-Fehmi R, Krause HB, Morris RT, Wallbillich JJ, Corey L, Bandyopadhyay S, Kheil M, Elbashir L, Zaiem F, Quddus MR, Abada E, Herzog T, Karnezis AN, Antonarakis ES, Kasi PM, Wei S, Swensen J, Elliott A, Xiu J, Hechtman J, Spetzler D, Abraham J, Radovich M, Sledge G, Oberley MJ, Bryant D. Ali-Fehmi R, et al. Among authors: kasi pm. JCO Precis Oncol. 2024 Oct;8:e2300648. doi: 10.1200/PO.23.00648. Epub 2024 Nov 20. JCO Precis Oncol. 2024. PMID: 39565978 Free PMC article.
Spectrum of Findings Seen in Patients With IDH1/2-Mutant Cholangiocarcinoma.
Kierans AS, Lutfi A, Afghan MK, Khan S, Javaid S, Currie BM, Rocca J, Samstein B, Golden E, Popa E, Hissong E, Kasi PM. Kierans AS, et al. Among authors: kasi pm. Int J Surg Pathol. 2024 Sep 24:10668969241271397. doi: 10.1177/10668969241271397. Online ahead of print. Int J Surg Pathol. 2024. PMID: 39314068
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial.
Dreyer MS, Mulcahy M, Kocherginsky M, Chen Y, Hochster HS, Kasi PM, Kircher S, Lou E, Ma Y, Uboha NV, Benson AB 3rd. Dreyer MS, et al. Among authors: kasi pm. Oncologist. 2024 Dec 6;29(12):1044-1050. doi: 10.1093/oncolo/oyae236. Oncologist. 2024. PMID: 39293067 Free PMC article. Clinical Trial.
Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary.
Fuentes Bayne HE, Kasi PM, Ma L, Hart LL, Wong J, Spigel DR, Schnabel CA, Reeves JA, Halfdanarson TR, Treuner K, Greco FA. Fuentes Bayne HE, et al. Among authors: kasi pm. JCO Precis Oncol. 2024 Sep;8:e2400191. doi: 10.1200/PO.24.00191. JCO Precis Oncol. 2024. PMID: 39231374 Free PMC article.
Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.
Reduzzi C, Nicolo' E, Singhal S, Venetis K, Ortega-Franco A, de Miguel-Perez D, Dipasquale A, Gouda MA, Saldanha EF, Kasi PM, Jantus-Lewintre E, Fusco N, Malapelle U, Gandara DR, Rolfo C, Serrano MJ, Cristofanilli M; International Society of Liquid Biopsy (ISLB). Reduzzi C, et al. Among authors: kasi pm. Crit Rev Oncol Hematol. 2024 Nov;203:104483. doi: 10.1016/j.critrevonc.2024.104483. Epub 2024 Aug 17. Crit Rev Oncol Hematol. 2024. PMID: 39159706 Review.
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A. Botta GP, et al. Among authors: kasi pm. Oncologist. 2024 Oct 3;29(10):859-869. doi: 10.1093/oncolo/oyae155. Oncologist. 2024. PMID: 39022993 Free PMC article.
185 results